Even as vaccines have reduced the risk of hospitalization and death from infection with SARS-CoV-2, researchers continue to worry about the individual suffering and population-wide threats from long COVID.
Pfizer said people 55 and older who got the omicron-targeting booster had four-fold higher antibody levels than those given an extra dose of the original vaccine.
School systems throughout the country reported using less than 15 percent of the latest round of federal education funding allotted during the last school year. Meanwhile, education advocates worry students continue to fall behind academically.
The percentage of preterm and low birthweight babies also went up last year, after holding steady for years. And more pregnant or postpartum women are reporting symptoms of depression.
Any variant that winds up dominating in coming months will probably challenge a key line of treatment and protection for people with compromised immune systems—the drugs known as monoclonal antibodies.
The FDA cleared the COVID-19 booster tweaks without requiring human test results—just like it approves yearly changes to flu vaccines.
Between 7 million and 23 million Americans—including 1 million who can no longer work—are suffering from the long-term effects of infection with the virus, according to government estimates.
While the vast majority of people who are infected with COVID do not experience complications, the risk of preeclampsia and other severe issues has been documented to be much higher with infection.
Worn down by a never-ending pandemic, some have stopped paying attention to health officials’ recommendations altogether, despite projections of a fall and winter COVID wave with the potential to sicken millions and kill tens of thousands, particularly the elderly and sick.
The national study co-authored by researchers at Indianapolis-based Regenstrief Institute and other agencies across the country was designed to gauge the effectiveness and durability of the third and fourth doses of COVID vaccine boosters.
The hope is that the modified boosters will help tamp down continuing COVID-19 cases and blunt another winter surge.
The new estimate is a dramatic increase from the roughly $16 billion in potential fraud identified a year ago, and it illustrates the immense task still ahead of Washington as it seeks to pinpoint the losses, recover the funds and hold criminals accountable.
The Centers for Disease Control and Prevention posted the count Thursday as public health experts bemoaned President Joe Biden’s recent remark that “the pandemic is over.”
The FDA’s inspection was focused on production issues at a Bloomington-based plant operated by Catalent, which is helping to bottle and package Moderna’s COVID-19 vaccine.
Federal prosecutors said the 47 defendants used a complex web of shell companies and bribes to obtain federal pandemic funds in the names of children who did not exist and then spent that money on luxury cars, houses and other personal purchases.
Doctors and public health experts never expected there would be so little interest in vaccines for young children.
During the first two years of the pandemic, the number of people working from home tripled, home values grew and the percentage of people who spent more than a third of their income on rent went up, according to survey results released Thursday by the U.S. Census Bureau.
In total, the Small Business Administration made 41,638 awards to applicants that pursued that aid using computers believed to be located abroad, according to the agency’s inspector general.
The partners will utilize the Indiana Network for Patient Care, which was created by Regenstrief and is managed by the Indiana Health Information Exchange, to mine data from electronic health records.
In recent months, current and former employees of drugmaker Eli Lilly and Co., medical-equipment maker Roche Diagnostics and health care system Ascension St. Vincent have filed suit in federal district court, claiming their religious views and civil liberties were violated.
